Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection
Background. Cytomegalovirus (CMV) antiviral drug resistance constitutes an increasing challenge in transplantation. Foscarnet is usually proposed when resistance for ganciclovir is suspected, but its use is limited by its nephrotoxicity. Case Presentation. We report a case of multiresistant CMV dise...
Saved in:
Main Authors: | Romain Vial, Christine Zandotti, Sophie Alain, Alexandre Decourt, Noémie Jourde-Chiche, Raj Purgus, Charleric Bornet, Laurent Daniel, Valérie Moal, Tristan Legris |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2017/3624146 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylaxis of Cytomegalovirus in Renal Transplant Recipients
by: Allan S MacDonald, et al.
Published: (1993-01-01) -
Oxazolidinones as an Alternative in the Treatment of Multiresistant Staphylococcus Aureus
by: Maira Quiros Enríquez, et al.
Published: (2013-04-01) -
Prevention and Treatment of Cytomegalovirus Infection in Transplant Recipients
by: Jutta K Preiksatis
Published: (1993-01-01) -
Original Approach for Automated Quantification of Antinuclear Autoantibodies by Indirect Immunofluorescence
by: Daniel Bertin, et al.
Published: (2013-01-01) -
Successful Treatment of Adenovirus Infection with Brincidofovir in an Immunocompromised Patient after Hematological Stem Cell Transplantation
by: T. Van Genechten, et al.
Published: (2020-01-01)